Skip to content

NRXP

NRX Pharmaceuticals, Inc.

NASDAQ · Healthcare · Biotechnology · US

$2.63
+1.15%
Ask drillr

Leverage

Debt / equity
-7.33x
Net debt / equity
149.65x
Debt / assets
0.04x
Debt / EBITDA
-0.06x
Net debt / EBITDA
1.16x

Liquidity & coverage

Current ratio
0.86x
Quick ratio
0.86x
Cash ratio
0.79x
Interest coverage
-17.45x
EBITDA / interest
-19.10x
Working capital
-$4.7M

Cash & dividend

FCF / debt
-16.59x
Cash flow / debt
-15.87x
Dividend per share
—
Dividend yield
—
Dividend growth 1y
—

Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026